Nyheter

Smaller patient groups and targeted treatments are the future of cancer care in Norway.

Learn more about the EU-funded Norwegian initiatives PCM4EU and PRIME-ROSE, and the Norwegian MATRIX Centre.

The third educational seminar in the clinical trials meeting series arranged by CONNECT Working Group 2 took place via Zoom on 13 February.

How can researchers have successful collaborations with industry in clinical studies? This was a central question at a recent CONNECT semina

Industry-sponsored clinical studies in Norway were in focus at the kick-off meeting for a new meeting series hosted by CONNECT Working Group

How can clinicians be more involved in healthcare decision-making? This was a central question at an educational seminar hosted by...

The first national initiatives for precision cancer medicine have successfully taken shape in Norway, but what has been achieved and what do

CONNECT welcomes the two new partners Gilead Sciences Nordic Region and the Norwegian Directorate for E-health.

Experts from regional, national and international groups shared their perspectives on digital pathology and artificial intelligence (AI)...